ICAM1 and colorectal cancer: In human patients, high expression of ICAM-1, VCAM-1, and MAdCAM-1 has been shown to correlate with higher density of CD8+ T cells in colorectal cancer (CRC) tumors and also with prolonged disease-free survival (128).